Table 5 Comparison of Radio-inducible cancer incidence rates by period and sub-cohort groupa
cancer | Region | Sex | Year | CR | ASR(95% CI) |
|---|---|---|---|---|---|
Thyroid ca. | Exposed | Male | 1992–2003 | 7.9 | 4.7(0–11.2) |
2004–2008 | 41.8 | 26.7(7.5–45.9) | |||
Female | 1992–2003 | 35.3 | 32.0(11.8–52.3) | ||
2004–2008 | 112.9 | 83.0(53.6–112.4) | |||
Control-1 | Male | 1992–2003 | 4.6 | 2.9(0–8.4) | |
2004–2008 | 52.1 | 29.8(10.2–49.5) | |||
Female | 1992–2003 | 35.7 | 13.5(4.0–23.1) | ||
2004–2008 | 82.2 | 73.0(34.6–111.4) | |||
Control-2 | Male | 1992–2003 | 4.7 | 7.3(0–21.5) | |
2004–2008 | 7.8 | 8.9(0–21.7) | |||
Female | 1992–2003 | 19.5 | 10.2(0.9–19.6) | ||
2004–2008 | 55.8 | 39.9(21.1–58.7) | |||
Liver ca. | Exposed | Male | 1992–2005 | 144.8 | 104.6(74.4–134.8) |
2006–2008 | 169.7 | 85.9(46.1–125.7) | |||
Female | 1992–2005 | 17.7 | 8.5(1.9–15.2) | ||
2006–2008 | 31.5 | 9.6(1.0–18.2) | |||
Control-1 | Male | 1992–2005 | 122.4 | 68.0(45.0–91.0) | |
2006–2008 | 147.8 | 55.2(26.1–84.4) | |||
Female | 1992–2005 | 33.3 | 14.2(5.2–23.2) | ||
2006–2008 | 30.7 | 9.8(0.4–19.2) | |||
Control-2 | Male | 1992–2005 | 171.3 | 89.1(62.1–116.1) | |
2006–2008 | 158.2 | 80.7(45.4–116.0) | |||
Female | 1992–2005 | 46.8 | 20.1(10.8–29.4) | ||
2006–2008 | 59.4 | 21.6(9.0–34.3) | |||
Stomach ca. | Exposed | Male | 1992–2005 | 213.2 | 155.4(117.7–193.1) |
2006–2008 | 273.6 | 108.5(69.1–147.9) | |||
Female | 1992–2005 | 91.3 | 47.7(30.6–64.7) | ||
2006–2008 | 131.6 | 54.6(28.5–80.7) | |||
Control-1 | Male | 1992–2005 | 211.3 | 117.2(86.7–147.8) | |
2006–2008 | 140.2 | 54.3(26.1–82.5) | |||
Female | 1992–2005 | 130.6 | 61.4(38.8–84.1) | ||
2006–2008 | 129.7 | 48.1(23.5–72.6) | |||
Control-2 | Male | 1992–2005 | 229.9 | 98.8(74.8–122.9) | |
2006–2008 | 267.2 | 129.3(83.7–174.9) | |||
Female | 1992–2005 | 87.1 | 45.6(29.2–62.0) | ||
2006–2008 | 106.5 | 41.4(23.0–59.9) |